marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
BioXcel Therapeutics Financial Ratios 2011-2024 | BTAI
Annual Financial Ratios BioXcel Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.5 | -0.5 | -4.4 | -12.2 | -8.6 | -4.1 | - | - | - | - | - | - | - |
P/S |
59.3 | 209.9 | - | 41328144.2 | - | - | - | - | - | - | - | - | - |
EPS |
-6.2 | -5.9 | -4.0 | -3.8 | -2.0 | -1.3 | -0.5 | - | - | - | - | - | - |
EV (Enterprise Value) |
147 M | 14.1 M | 260 M | 804 M | 261 M | 41.9 M | 1.45 M | 331 K | - | - | - | - | - |
EBITDA per Share |
-5.89 | -5.69 | -4.04 | -3.79 | -2.05 | -1.37 | - | - | - | - | - | - | - |
EV/EBITDA |
-2.4 | -9.6 | -7.5 | -1.9 | - | - | - | - | - | - | - | ||
PEG |
- | 0.14 | 0.16 | 0.01 | - | - | - | - | - | - | - | ||
P/B |
-1.4 | 1.0 | 2.1 | 4.9 | 10.6 | 2.1 | - | - | - | - | - | - | - |
P/CF |
-0.5 | -0.6 | -5.8 | -15.1 | -10.1 | -5.8 | - | - | - | - | - | - | - |
ROE % |
316.86 | -215.90 | -48.24 | -39.75 | -122.58 | -49.55 | - | - | - | - | - | - | - |
ROA % |
-242.94 | -80.52 | -44.66 | -37.36 | -90.59 | -44.25 | - | - | - | - | - | - | - |
ROCE % |
304.00 | -207.94 | -48.24 | -39.55 | -120.33 | -51.33 | - | - | - | - | - | - | - |
Current Ratio |
0.6 | 1.6 | 13.5 | 18.3 | 4.0 | 9.3 | - | - | - | - | - | - | - |
DSO |
42.2 | 120.7 | - | - | - | - | - | - | - | - | - | - | - |
DIO |
575.9 | 18113.1 | - | - | - | - | - | - | - | - | - | - | - |
DPO |
3459.1 | 136017.2 | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
618.1 | 18233.8 | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
-2841.0 | -117783.4 | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios BioXcel Therapeutics
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.32 | -0.21 | - | -1.72 | -1.83 | - | - | -1.49 | -1.35 | -1.12 | - | -0.96 | -1.11 | -1.08 | - | -1.07 | -1.06 | -0.79 | - | -0.57 | -0.54 | -0.46 | - | -0.31 | -0.19 | -0.37 | - | -0.1 | -0.06 | -0.06 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.36 | -0.43 | - | -1.65 | -1.79 | - | - | -1.39 | -1.29 | -1.12 | - | -0.96 | -1.1 | -1.07 | - | -1.07 | -1.05 | -0.79 | - | -0.57 | -0.54 | -0.47 | - | -0.33 | -0.21 | -0.37 | - | -0.1 | -0.06 | -0.06 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
275.76 | -652.78 | -887.88 | -920.80 | -1078.05 | -188.38 | -72.07 | -82.99 | -60.99 | -48.39 | -35.37 | -47.35 | -48.40 | -48.44 | -29.55 | -63.08 | -84.64 | -105.77 | -91.81 | -104.38 | -83.42 | -59.70 | -31.36 | 62.02 | 167.97 | 233.29 | 204.79 | 204.79 | 111.41 | 53.87 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-141.12 | -151.40 | -88.46 | -105.53 | -72.35 | -49.33 | -47.16 | -57.42 | -50.61 | -45.26 | -33.25 | -44.50 | -45.50 | -45.41 | -27.77 | -52.55 | -66.08 | -79.62 | -67.85 | -79.07 | -65.52 | -49.19 | -28.00 | -95.68 | -152.13 | -186.88 | -148.41 | -148.41 | -80.74 | -39.04 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
279.01 | -632.68 | -774.89 | -805.60 | -955.24 | -83.50 | -69.02 | -79.94 | -60.15 | -48.39 | -35.37 | -47.35 | -48.42 | -48.46 | -29.61 | -63.57 | -85.55 | -107.28 | -93.65 | -106.82 | -86.02 | -62.25 | -32.53 | 60.85 | 167.40 | 233.28 | 204.79 | 204.79 | 111.41 | 53.87 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
0.4 | 0.5 | 0.6 | 0.7 | 1.0 | - | 1.6 | 2.1 | 3.0 | 12.4 | 13.5 | 16.6 | 20.5 | 14.7 | 16.6 | 16.6 | 16.6 | 16.6 | 3.8 | 3.8 | 3.8 | 3.8 | 9.3 | 9.3 | 9.3 | 9.3 | 0.6 | 0.6 | 0.6 | 0.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
173.8 | 36.5 | - | 156.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
164.0 | 3437.3 | - | 351.4 | - | - | - | 11626.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
1097.5 | 19802.7 | - | 1949.0 | - | - | - | 49328.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
337.7 | 3473.8 | - | 507.4 | - | - | - | 11626.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
-759.8 | -16328.9 | - | -1441.7 | - | - | - | -37702.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency